1AI 11.1% 1.0¢ algorae pharmaceuticals limited

Ann: NTCELL and Parkinson's Clinical Trial Update, page-10

  1. 11,859 Posts.
    lightbulb Created with Sketch. 6012
    May it is then 2018, The quarterly will be out before then so will garnish more info on the Company position from that.
    One year follow up data in patients from all three groups of the Phase IIb study will be announced in May 2018. To release data on patients in selected groups of that trial when all data are not available may falsely affect the outcome of those yet to reach the one year mark. The Board has also decided to continue follow-up until May 2019. 2019 ??
    Still placing it all on NTcell, no updates on Diabecell , meeting with the Japanese JV partners etc, but i guess this mornings meeting was just a short one.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
1.0¢
Change
0.001(11.1%)
Mkt cap ! $16.87M
Open High Low Value Volume
0.8¢ 1.0¢ 0.8¢ $1.09K 110.0K

Buyers (Bids)

No. Vol. Price($)
4 185000 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 783729 2
View Market Depth
Last trade - 14.38pm 18/07/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.